Crescent Biopharma, Inc.
CBIO
$10.35
-$0.75-6.76%
NASDAQ
Corporate Info
Website
Phone Number
617 460 5595
Address
300 Fifth Avenue
Waltham, MA 02451
Waltham, MA 02451
Country
United States
Year Founded
2024
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
41
Business Description
Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics. The company was formerly known as GlycoMimetics, Inc. The company was founded in 2024 and is headquartered in Waltham, Massachusetts.